BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12
114 results:

  • 1. Risk of secondary primary malignancies in survivors of upper tract urothelial carcinoma: A nationwide population-based analysis.
    Wu KY; Cheong IS; Lai JN; Hu CY; Hung KC; Chen YT; Chiu LT; Tsai HT; Jou YC; Tzai TS; Tsai YS
    Cancer Epidemiol; 2024 Apr; 89():102536. PubMed ID: 38281454
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comprehensive analysis reveals the involvement of hsa_circ_0037858/miR-5000-
    Nianyong Y; Li G
    Aging (Albany NY); 2023 Jun; 15(12):5399-5411. PubMed ID: 37379126
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tumoricidal Activity of Simvastatin in Synergy with rhoa Inactivation in Antimigration of Clear Cell Renal Cell Carcinoma Cells.
    Lee YG; Chou FN; Tung SY; Chou HC; Ko TL; Fann YC; Juan SH
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298689
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Preclinical Evidence that Arctigenin Effectively and Selectively Targets Clear Cell Renal Cell Carcinoma Via Suppressing EGFR and rhoa.
    Liu D; Zhou G; Xu M
    Nutr Cancer; 2023; 75(5):1373-1381. PubMed ID: 36947006
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm.
    Tappero S; Barletta F; Piccinelli ML; Cano Garcia C; Incesu RB; Morra S; Scheipner L; Tian Z; Parodi S; Dell'Oglio P; Palumbo C; Briganti A; De Cobelli O; Chun FKH; Graefen M; Longo N; Ahyai S; Saad F; Shariat SF; Suardi N; Borghesi M; Terrone C; Karakiewicz PI
    Eur Urol Focus; 2023 Sep; 9(5):742-750. PubMed ID: 36906483
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pathological and Clinical Outcomes in a Large Surveillance and Intervention Cohort of Radiographically Cystic Renal Masses.
    Lee RA; Uzzo RG; Anaokar J; Thomas A; Wei S; Ristau BT; McIntosh A; Lee M; Chen DYT; Greenberg RE; Viterbo R; Smaldone MC; Correa A; Schober J; Ginsburg K; Bukavina L; Magee D; Uzzo N; Parkansky P; Ruth K; Kutikov A
    J Urol; 2023 Apr; 209(4):686-693. PubMed ID: 36630588
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A review on the role of PCGEM1 lncRNA in cancer.
    Ghafouri-Fard S; Khoshbakht T; Hussen BM; Baniahmad A; Taheri M; Mokhtari M
    Pathol Res Pract; 2022 Dec; 240():154223. PubMed ID: 36403313
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical and economic burdens of recurrence following nephrectomy for intermediate high- or high-risk renal cell carcinoma: A retrospective analysis of Surveillance, Epidemiology, and End Results-Medicare data.
    Sundaram M; Song Y; Rogerio JW; Zhang S; Bhattacharya R; Adejoro O; Carley C; Zhu JJ; Signorovitch J; Haas NB
    J Manag Care Spec Pharm; 2022 Oct; 28(10):1149-1160. PubMed ID: 36048895
    [No Abstract]    [Full Text] [Related]  

  • 9. The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?
    Qi Y; Duan G; Wei D; Zhao C; Ma Y
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014536
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Construction and validation of a prognostic model for kidney renal clear cell carcinoma based on podocyte-associated genes.
    Chen C; Yang RX; Zhang JX; Xu HG
    Cancer Med; 2022 Oct; 11(19):3549-3562. PubMed ID: 35373928
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. YAP1 activation promotes epithelial-mesenchymal transition and cell survival of renal cell carcinoma cells under shear stress.
    Chen X; Zhang X; Jiang Y; Zhang X; Liu M; Wang S; Liu S; Liang H; Liu C
    Carcinogenesis; 2022 May; 43(4):301-310. PubMed ID: 35147702
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Ultrasound-Guided Renal Mass Biopsy and Its Clinical Utility: A Single-Centre Experience.
    Jasinski M; Siekiera J; Tworkiewicz M
    Urol Int; 2022; 106(6):560-566. PubMed ID: 35066507
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Function of selected natural antidiabetic compounds with potential against cancer via modulation of the PI3K/AKT/mTOR cascade.
    Nurcahyanti ADR; Jap A; Lady J; Prismawan D; Sharopov F; Daoud R; Wink M; Sobeh M
    Biomed Pharmacother; 2021 Dec; 144():112138. PubMed ID: 34750026
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.
    Tian X; Xu WH; Wu JL; Gan HL; Wang HK; Gu WJ; Qu YY; Zhang HL; Ye DW
    Pathol Oncol Res; 2021; 27():1609809. PubMed ID: 34512202
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer.
    Kubota Y; Hatakeyama S; Yoneyama T; Yoneyama MS; Hamano I; Konishi S; Okamoto T; Yamamoto H; Yoneyama T; Hashimoto Y; Ohyama C
    World J Urol; 2021 Sep; 39(9):3265-3271. PubMed ID: 33675416
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Yes-Associated Protein 1 Is a Novel Calcium Sensing Receptor Target in Human Parathyroid tumors.
    Tavanti GS; Verdelli C; Morotti A; Maroni P; Guarnieri V; Scillitani A; Silipigni R; Guerneri S; Maggiore R; Mari G; Vicentini L; Dalino Ciaramella P; Vaira V; Corbetta S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670622
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Systematic Analysis of the Global, Regional and National Burden of kidney Cancer from 1990 to 2017: Results from the Global Burden of Disease Study 2017.
    Zhan Y; Pan C; Zhao Y; Li J; Wu B; Bai S
    Eur Urol Focus; 2022 Jan; 8(1):302-319. PubMed ID: 33509670
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. KANK family proteins in cancer.
    Tadijan A; Samaržija I; Humphries JD; Humphries MJ; Ambriović-Ristov A
    Int J Biochem Cell Biol; 2021 Feb; 131():105903. PubMed ID: 33309958
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. p53-dependent elimination of aneuploid mitotic offspring by entosis.
    Liang J; Niu Z; Zhang B; Yu X; Zheng Y; Wang C; Ren H; Wang M; Ruan B; Qin H; Zhang X; Gu S; Sai X; Tai Y; Gao L; Ma L; Chen Z; Huang H; Wang X; Sun Q
    Cell Death Differ; 2021 Feb; 28(2):799-813. PubMed ID: 33110215
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Survival following cytoreductive nephrectomy: a comparison of existing prognostic models.
    Westerman ME; Shapiro DD; Tannir NM; Campbell MT; Matin SF; Karam JA; Wood CG
    BJU Int; 2020 Dec; 126(6):745-753. PubMed ID: 32623821
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.